Top compounds associated with response to OR4K13


Feature Type Standardized
Nominal ANOVA
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA AT-7519 GDSC1000 pan-cancer AAC -0.039 0.2
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA PL-DI CTRPv2 pan-cancer AAC -0.04 0.2
mRNA UNC0638 GDSC1000 pan-cancer AAC -0.039 0.2
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.041 0.2
mRNA ABT-888 CTRPv2 pan-cancer AAC -0.047 0.2
mRNA thalidomide CTRPv2 pan-cancer AAC -0.068 0.2
mRNA Vinorelbine GDSC1000 pan-cancer AAC -0.046 0.2
mRNA GSK-650394 GDSC1000 pan-cancer AAC -0.046 0.2
Download CSV